GADSDEN REPORT
Don't Tread On The Truth
Economy & Markets

GLP-1 injections recalled nationwide over sterility concerns

The FDA classified Apothecary Pharma's nationwide recall of 23 injectable drug vials as Class II. The company previously received a warning over sterile drug production. Read more at FOX BIZ ›
Read the full story at
FOX BIZ
Open the original

The Gadsden Report aggregates and summarises headlines. The reporting above belongs to FOX BIZ, and the link opens their page. This page exists so readers can find, share, and discuss the story here.

Discussion — 0 comments

No comments yet. Be the first.